News

ALS Image

February 13, 2020

Biotechnology License Agreement Bloom Science Granted Exclusive Option to License Gut Microbiome-based Therapies for ALS, Other Neurological Disorders

Bloom Science and Duke University have entered into an exclusive licensing agreement that...

MORE >
Startup Elle Ventures

February 13, 2020

Duke Innovations Start-ups Venture Capital Female investors sought for startups

A new angel investor network in the Triangle is taking...

MORE >
NC Biotech Center

February 10, 2020

Grant Biotechnology NCBiotech awards $2.1M in grants, loans

The North Carolina Biotechnology Center has awarded 23 grants and loans...

MORE >
Phasebio Logo

February 10, 2020

Biotechnology Start-ups PhaseBio Announces Case Study Highlighting PB1046 Hemodynamic Data

Presented at the 14th Pulmonary Vascular Research Institute World Congress...

MORE >
Duke NFL

January 31, 2020

Engineering Duke News Duke Trio Named Finalists for NFL Honor

Former Duke football lettermen Clark Bulleit, Kevin Gehsmann, and Tim Skapek have been...

MORE >

January 29, 2020

Duke Innovations Start-ups Polarean Imaging plc Announces Positive Results From Pivotal Phase III Clinical Trials

Polarean Imaging plc (AIM: POLX), a clinical stage medical imaging...

MORE >
Test Tubes Eli Lilly

January 27, 2020

Press Releases Durham/Triangle News Eli Lilly and Company taps Durham for 450+ jobs, new facility

Eli Lilly and Company plans to bring more than 462...

MORE >
Venture Capital

January 25, 2020

Start-ups Venture Capital More than 100 companies to participate in CED’s new look venture event

More than 100 entrepreneurial companies will be participating in the...

MORE >
Duke Re

January 25, 2020

Research 2019 WAS A BANNER YEAR FOR SOLUTIONS-ORIENTED RESEARCH AT DUKE

More than a billion dollars invested in new talent and...

MORE >
DNA strand assembling from different elements. 3D illustration

January 21, 2020

Duke Innovations Biotechnology Press Releases Sarepta plans gene editing center; files DMD therapy for review

Genetic disease-focused firms need infrastructure says Sarepta, which shared plans...

MORE >